Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
10 May 2023
Historique:
received: 15 12 2022
accepted: 03 05 2023
medline: 12 5 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: epublish

Résumé

Urothelial carcinoma arises from the inner urothelial membrane of the renal pelvis, ureter, and bladder and often causes macrohematuria. Here, we report a rare case in which the patient developed non-symptomatic urothelial carcinoma anatomically outside the bladder wall 17 years after bladder diverticulectomy. An 82-year-old male patient previously underwent gastrectomy for stomach cancer and partial hepatectomy for intrahepatic cholangiocarcinoma. Follow-up computed tomography revealed a tumor in the retroperitoneal space, where a bladder diverticulum was removed 17 years earlier. Multiparametric magnetic resonance imaging suggested that the tumor was malignant with rectal invasion. Subsequent computed tomography-guided percutaneous biopsy revealed that the tumor was urothelial carcinoma. The patient underwent two courses of neoadjuvant chemotherapy followed by pelvic exenteration with pelvic lymph node dissection. He is currently receiving adjuvant therapy with an immune checkpoint inhibitor and has had no recurrence for 3 months. Multiparametric magnetic resonance imaging is a helpful tool for predicting both tumor malignancy and invasion before a pathologically confirmed diagnosis. Although this case is rare, urologists should be aware of the occurrence of urothelial carcinoma after bladder diverticulectomy in cases of incomplete resection of the diverticulum.

Sections du résumé

BACKGROUND BACKGROUND
Urothelial carcinoma arises from the inner urothelial membrane of the renal pelvis, ureter, and bladder and often causes macrohematuria. Here, we report a rare case in which the patient developed non-symptomatic urothelial carcinoma anatomically outside the bladder wall 17 years after bladder diverticulectomy.
CASE PRESENTATION METHODS
An 82-year-old male patient previously underwent gastrectomy for stomach cancer and partial hepatectomy for intrahepatic cholangiocarcinoma. Follow-up computed tomography revealed a tumor in the retroperitoneal space, where a bladder diverticulum was removed 17 years earlier. Multiparametric magnetic resonance imaging suggested that the tumor was malignant with rectal invasion. Subsequent computed tomography-guided percutaneous biopsy revealed that the tumor was urothelial carcinoma. The patient underwent two courses of neoadjuvant chemotherapy followed by pelvic exenteration with pelvic lymph node dissection. He is currently receiving adjuvant therapy with an immune checkpoint inhibitor and has had no recurrence for 3 months.
CONCLUSIONS CONCLUSIONS
Multiparametric magnetic resonance imaging is a helpful tool for predicting both tumor malignancy and invasion before a pathologically confirmed diagnosis. Although this case is rare, urologists should be aware of the occurrence of urothelial carcinoma after bladder diverticulectomy in cases of incomplete resection of the diverticulum.

Identifiants

pubmed: 37165362
doi: 10.1186/s12894-023-01266-x
pii: 10.1186/s12894-023-01266-x
pmc: PMC10173469
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88

Informations de copyright

© 2023. The Author(s).

Références

Indian J Radiol Imaging. 2022 Jul 13;32(2):235-252
pubmed: 35924125
Radiographics. 2012 Mar-Apr;32(2):371-87
pubmed: 22411938
Rev Urol. 2016;18(2):114-7
pubmed: 27601971
J Urol. 2004 Jun;171(6 Pt 1):2151-4
pubmed: 15126775
J Urol. 2003 Nov;170(5):1761-4
pubmed: 14532771
Eur Urol. 2004 Oct;46(4):442-3
pubmed: 15363557
AJR Am J Roentgenol. 2020 Jun;214(6):1259-1268
pubmed: 32286874
Urology. 1984 Jun;23(6):573-7
pubmed: 6428024
Radiographics. 2011 Jul-Aug;31(4):949-76
pubmed: 21768233
BJU Int. 2015 Apr;115(4):625-32
pubmed: 24905868
J Endourol Case Rep. 2020 Dec 29;6(4):366-369
pubmed: 33457675

Auteurs

Akira Ohtsu (A)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Seiji Arai (S)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan. a-seiji@gunma-u.ac.jp.

Yuji Fujizuka (Y)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Reon Fukuda (R)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Keisuke Hori (K)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Yuki Morimura (Y)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Rintaro Kawahara (R)

Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Takuya Shiraishi (T)

Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Hiroomi Ogawa (H)

Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Yoshiyuki Miyazawa (Y)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Masashi Nomura (M)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Yoshitaka Sekine (Y)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Hidekazu Koike (H)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Hiroshi Matsui (H)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Kazuhiro Suzuki (K)

Department of Urology, Gunma University Hospital, 3-39-15, Showa-Machi, Maebashi, Gunma, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH